We are live on ! Find out more
LOGC

LogicBio Therapeutics, Inc. Common Stock
LOGC

Delisted

LOGC was delisted on the 15th of November, 2022.

Back to rankings

59 hedge funds and large institutions have $133M invested in LogicBio Therapeutics, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 26 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

333% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 6

160% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 5

36% more capital invested

Capital invested by funds: $97.5M → $133M (+$35.2M)

16% more funds holding

Funds holding: 51 → 59 (+8)

Holders
59
Holders Change
+8
Holders Change %
+15.69%
% of All Funds
1.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
26
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$13.4M
2
Franklin Resources
Franklin Resources
California
+$6.01M
3
EC
EcoR1 Capital
California
+$5.18M
4
SC
Samlyn Capital
New York
+$4.31M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$3.35M

Top Sellers

Rank Fund Capital Flow
1
JG
Jefferies Group
New York
-$308K
2
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$288K
3
Russell Investments Group
Russell Investments Group
United Kingdom
-$250K
4
JP Morgan Chase
JP Morgan Chase
New York
-$143K
5
TRCT
Tower Research Capital (TRC)
New York
-$66.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
State of Wisconsin Investment Board
26
State of Wisconsin Investment Board
Wisconsin
$174K +$153K +22,800 New
Jacobs Levy Equity Management
27
Jacobs Levy Equity Management
New Jersey
$154K -$288K -42,976 -68%
Barclays
28
Barclays
United Kingdom
$154K +$78K +11,656 +137%
Wells Fargo
29
Wells Fargo
California
$138K +$38.1K +5,696 +46%
HSBC Holdings
30
HSBC Holdings
United Kingdom
$118K +$103K +15,396 New
PPA
31
Parametric Portfolio Associates
Washington
$111K +$97.4K +14,563 New
RhumbLine Advisers
32
RhumbLine Advisers
Massachusetts
$100K +$11.5K +1,720 +15%
Bank of America
33
Bank of America
North Carolina
$99K +$40.5K +6,057 +88%
Deutsche Bank
34
Deutsche Bank
Germany
$90K +$31.3K +4,681 +66%
Manulife (Manufacturers Life Insurance)
35
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$90K +$78.8K +11,781 New
IWM
36
IHT Wealth Management
Illinois
$86K -$1.34K -200 -2%
New York State Common Retirement Fund
37
New York State Common Retirement Fund
New York
$44K – – –
Bank of Montreal
38
Bank of Montreal
Ontario, Canada
$32K +$12.2K +1,818 +92%
Citigroup
39
Citigroup
New York
$25K +$16.4K +2,454 +277%
BNP Paribas Financial Markets
40
BNP Paribas Financial Markets
France
$23.5K -$1.05K -157 -5%
UBS Group
41
UBS Group
Switzerland
$23K +$19.6K +2,934 +2,081%
Legal & General Group
42
Legal & General Group
United Kingdom
$16K +$3.67K +549 +36%
TRCT
43
Tower Research Capital (TRC)
New York
$15K -$66.7K -9,977 -84%
US Bancorp
44
US Bancorp
Minnesota
$15K – – –
Royal Bank of Canada
45
Royal Bank of Canada
Ontario, Canada
$11K +$5.65K +845 +117%
EWM
46
Endurance Wealth Management
Rhode Island
$11K +$10K +1,500 New
AIP
47
Ameritas Investment Partners
Nebraska
$5K – – –
SIS
48
Sound Income Strategies
Florida
$5K – – –
JMF
49
Johnson Midwest Financial
Iowa
$5K +$4.78K +715 New
FCH
50
Freestone Capital Holdings
Washington
$4.58K – – –
1
2
3

LOGC Hedge Fund Activity: Q4 2020 in Review

59 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in LogicBio Therapeutics, Inc. Common Stock (LOGC) for Q4 2020, worth a combined $133M — up 36% from $97.5M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new LOGC positions and 5 closed out — a net gain of 8 holders — while 26 added to existing stakes and 6 trimmed.

The largest buyer was OrbiMed, adding an estimated $13.4M. The largest seller was Jefferies Group, exiting entirely with an estimated $308K sold.

  • 59 institutional investors held LogicBio Therapeutics, Inc. Common Stock (LOGC) as of Q4 2020, up from 51 in Q3 2020.
  • Funds reported $133M of LogicBio Therapeutics, Inc. Common Stock stock for Q4 2020, up 36% quarter-over-quarter.
  • 13 funds opened new LogicBio Therapeutics, Inc. Common Stock positions in Q4 2020 and 5 closed out, a net change of +8 holders.
  • The largest LogicBio Therapeutics, Inc. Common Stock buyer in Q4 2020 was OrbiMed, an estimated $13.4M added.
  • The largest LogicBio Therapeutics, Inc. Common Stock seller in Q4 2020 was Jefferies Group, an estimated $308K sold.

Based on aggregated 13F filings for Q4 2020.